about
Understanding and reducing disability in older adults following critical illnessReversal of myoblast aging by tocotrienol rich fraction posttreatmentMusculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study.Association of Fatigue With Sarcopenia and its Elements: A Secondary Analysis of SABE-Bogotá.Examining the association between anthropometric parameters and telomere length and mortality risk.A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α.Comparative associations of muscle mass and muscle strength with mortality in dialysis patients.Geriatric medicine in an aging society: up for a challenge?Protein intake and muscle function in older adultsSarcopenia-related features and factors associated with lower muscle strength and physical performance in older Chinese: a cross sectional study.Predictive Values of the New Sarcopenia Index by the Foundation for the National Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults.Health Outcomes of Sarcopenia: A Systematic Review and Meta-AnalysisThe Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study.Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia.Sarcopenia and mortality among a population-based sample of community-dwelling older adultsImpact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort studyCalf circumference predicts mobility disability: A secondary analysis of the Mexican health and ageing study.A validation of the application of D(2)O stable isotope tracer techniques for monitoring day-to-day changes in muscle protein subfraction synthesis in humans.Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study.Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention.Availability and use of dual energy X-ray absorptiometry (DXA) and bio-impedance analysis (BIA) for the evaluation of sarcopenia by Belgian and Latin American geriatricians.Systematic Literature Review and Meta-Analysis of the Association of Sarcopenia With Mortality.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study.Validity of Knee-Estimated Height to Assess Standing Height in Older Adults: A Secondary Longitudinal Analysis of the Mexican Health and Aging Study.Relationship between Handgrip Strength and Muscle Mass in Female Survivors of Breast Cancer: A Mediation Analysis.Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality.Association of postdischarge rehabilitation with mortality in intensive care unit survivors of sepsis.Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly.Sarcopenia definitions: where to draw the line? Response to Scarlata et al.Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.Sarcopenia based on the Asian Working Group for Sarcopenia criteria and all-cause mortality risk in older Japanese adults.Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatment.Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults.Prevalence and associated factors of sarcopenia and severe sarcopenia in older Taiwanese living in rural community: the Tianliao Old People study 04.Impact of body mass index on the relationship between muscle quality and physical function in older women.[Gender aspects of malnutrition and associated sequelae. Prevention and therapy].Intake of low-dose leucine-rich essential amino acids stimulates muscle anabolism equivalently to bolus whey protein in older women at rest and after exercise.Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study.
P2860
Q27022951-F23EEA5F-09FD-4BA5-B668-6F120A1E406FQ28392576-B5CD3141-7C6F-4D66-8A22-0AAE382AF18BQ31151507-60063404-965F-4C4D-B1AE-888B7C27EDF6Q33610493-A0D271FE-E51F-4FF0-9C14-3008D58FA8C1Q33798271-FF9E4626-61EA-4333-A81D-0E46AD6F3DD8Q33901304-00E9FF78-0B2F-46AA-B123-36DCAD5A676CQ34292906-E8B33DD6-3FCF-4B10-ABE9-6297728CF797Q35104440-7100D79D-5F07-45D3-B733-4078B3B74FEFQ35376863-903B58B0-8F0C-4306-9E11-4A51FD3DF0B6Q35924506-8CAE8044-2AA6-4AE9-BDF4-B68F4E8248D3Q36188713-576FBFB8-1F6B-4D98-A295-5714FB468F89Q36251208-7CFC5871-F204-4A5B-9C77-61D260F03D1AQ36492369-314C77FB-4A0C-43C0-BC56-1D92CE75BB63Q36500787-B60E526D-6ECF-4C53-8013-ACC66B2875AEQ36893199-EEDEB588-DE49-4175-9478-83E8E082FCF4Q37134141-79EF6B2F-14E0-4077-8CA0-ACD8F00810F2Q37265782-9EE1162C-51EB-4628-8FD0-6E14BA41C752Q37629020-914139BB-3701-4C54-868B-B7E8C6691D0DQ37709592-3BF70274-06AB-4830-BFBD-887384C14500Q37734770-388FAE9D-AD3E-41A4-810E-FD2B669B508CQ38264617-E8E35712-2C7B-4F7E-A955-4BBC7725A797Q38268458-32FA349A-5D23-44FE-B9C1-776A440FF3D3Q38722554-CB8320C6-F11D-4504-947E-727BA12EF837Q38842194-8EE617D5-2ACF-42BD-8691-2CEE82A5A333Q38887479-DE554741-14AF-42DB-85B1-9DC20FB54199Q38937655-3C4A9218-3059-4E08-B4C6-597413F8D4CEQ41195096-AC0B7BFD-6837-42B0-9B70-98F49268EB29Q41723281-0D1DEF26-6045-49CC-AFA0-A337169B0F01Q41743549-126A48B6-51E2-41EE-A14A-8A28AFD9B86DQ43510632-1A45037C-A198-453B-A680-DE6DCE563C9EQ44698774-3E9A9F4D-7D52-47E9-A050-C3237F8842C8Q45933573-742EE79F-7959-4918-8DC8-B00F99880AD4Q47571870-95F6A6F0-8B5D-4F53-8A34-8A15C4E51ACEQ48534891-171AC2D9-211C-435F-9CAC-91466F50324EQ49154613-49D5D72F-1463-4089-BDFC-31D9D1BEFF39Q50664246-6B2C78B4-7D9C-4869-9592-FA46177F1063Q50705018-A2728AEA-755D-4247-A068-024C74776DB6Q50798813-82A302FF-4A1B-40DC-881B-E153D9EC2F9DQ51038294-7546037F-FC03-4A88-93EB-EFD3A4D2C02DQ51093278-279E136B-4CEC-420B-AD3D-0C2E11945719
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mortality as an adverse outcome of sarcopenia.
@ast
Mortality as an adverse outcome of sarcopenia.
@en
type
label
Mortality as an adverse outcome of sarcopenia.
@ast
Mortality as an adverse outcome of sarcopenia.
@en
prefLabel
Mortality as an adverse outcome of sarcopenia.
@ast
Mortality as an adverse outcome of sarcopenia.
@en
P2093
P2860
P1476
Mortality as an adverse outcome of sarcopenia
@en
P2093
V E Arango-Lopera
P2860
P2888
P304
P356
10.1007/S12603-012-0434-0
P577
2013-03-01T00:00:00Z